Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature
Journal of Medical Case Reports volume 16, Article number: 222 (2022)
The optimal management for peritoneal dissemination in patients with hepatocellular carcinoma remains unclear. Although several reports have described the usefulness of surgical resection, the indications should be carefully considered. Herein, we report the case of a patient with hepatocellular carcinoma with peritoneal recurrence who underwent surgical resection using an indocyanine green fluorescence navigation system and achieved favorable disease control.
A 45-year-old Asian woman underwent left hemihepatectomy for a ruptured hepatocellular carcinoma. Seventeen months after the initial surgery, a single nodule near the cut surface of the liver was detected on computed tomography, along with elevation of tumor markers. The patient was diagnosed with peritoneal metastasis and underwent a surgical resection. Twelve months later, a single nodule on the dorsal side of the right hepatic lobe was detected on computed tomography, and we performed surgical resection. Indocyanine green (0.5 mg/kg) was intravenously administered 3 days before surgery, and the indocyanine green fluorescence imaging system revealed clear green fluorescence in the tumor, which helped us perform complete resection. Indocyanine green fluorescence enabled the detection of additional lesions that could not be identified by preoperative imaging, especially in the second metastasectomy. There was no further recurrence at 3 months postoperatively.
When considering surgical intervention for peritoneal recurrence in patients with hepatocellular carcinoma, complete resection is mandatory. Given that disseminated nodules are sometimes too small to be detected by preoperative imaging studies, intraoperative indocyanine green fluorescence may be an essential tool for determining the indications for surgical resection.
Peritoneal dissemination is a rare form of recurrence in hepatocellular carcinoma (HCC), and it has been reported that implantation of tumor cells by rupture of the primary tumor , needle biopsy, and radiofrequency ablation (RFA)  can cause peritoneal dissemination. Patients with HCC with peritoneal recurrence have poor prognosis, but surgery has been reported to improve prognosis . Indocyanine green (ICG), which fluoresces green when irradiated with near-infrared light, has been used not only for assessment of liver function but also for surgical navigation. Recent reports have shown that the ICG fluorescence pattern is useful for distinguishing between tumor and normal tissues for both primary and extrahepatic lesions of HCC [4,5,6]. It has also been reported that ICG accumulates better in highly differentiated than moderately or poorly differentiated HCC . In this report, we describe the case of a patient with HCC with peritoneal recurrence whose disease was well controlled by a surgical approach, including the ICG fluorescence navigation system. We also performed surgical resection twice for peritoneal dissemination of HCC using indocyanine green fluorescence imaging, including microlesions that could not be identified preoperatively.
A 45-year-old Asian woman with history of diabetes mellitus visited her family doctor with a chief complaint of epigastric pain. Contrast computed tomography (CT) revealed a 45-mm-diameter tumor with extravasation in liver segment S3/4, indicating HCC rupture (Fig. 1a). Transcatheter arterial embolization (TAE) was performed immediately, and the patient was referred to our hospital for radical surgery. The serum tumor markers alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) were markedly elevated (AFP: 3367 ng/mL, PIVKA-II: 885 mAU/mL). She was negative for hepatitis B and C, but had a fatty liver. Liver function was normal (Child–Pugh score, 5 points; grade A). We performed a left hemihepatectomy (Fig. 1b) 1 month after TAE. Histologically, the tumor was confirmed to be moderately differentiated HCC (Fig. 1c). There was no vascular invasion, lymph node metastasis, or intrahepatic metastasis. The surgical margins were negative. The pathological stage was II, according to the staging system of the Liver Cancer Study Group of Japan .
Seventeen months after the initial surgery, CT revealed a 10-mm nodule near the cut surface of the liver (Fig. 2a), together with mild elevation of AFP and PIVKA-II (AFP: 76 ng/mL, PIVKA-II: 41 mAU/mL). We diagnosed peritoneal recurrence of HCC and performed laparotomy. Given that the tumor was undetectable by ultrasonography, ICG 0.5 mg/kg was administered intravenously 3 days before the surgery and a metallic marker was placed the day before the surgery for reliable identification and complete resection of the tumor. Intraoperative findings showed a metallic marker in the fatty tissue of the lesser omentum; however, the boundary of the tumor was unclear (Fig. 2b). Near-infrared imaging showed ICG accumulation with a clear boundary around the metallic marker and absence of other lesions, which enabled us to secure the surgical margin (Fig. 2c). Histopathological examination revealed enriched growth of atypical cells, indicating peritoneal dissemination of the HCC (Fig. 2d).
Twelve months after resection of the peritoneal dissemination, a CT scan revealed a 12-mm nodule on the dorsal side of the lower part of the right liver lobe (Fig. 3a) with elevation of AFP and PIVKA-II (AFP: 72 ng/mL, PIVKA-II: 47 mAU/mL). Preoperative imaging analysis showed no other lesions; therefore, we decided to repeat surgical resection. Based on tumor location, we chose the laparoscopic approach, and ICG fluorescence imaging was used to identify the tumor (Fig. 3b). Intraoperatively, two disseminated lesions were detected by careful examination with ICG fluorescence (Fig. 3c, d). All lesions were resected, and R0 resection was achieved, resulting in immediate normalization of tumor markers. Histopathologically, all the lesions were diagnosed as peritoneal dissemination of HCC (Fig. 3e). The patient is alive and monitored in an outpatient setting; no recurrence has been noted 3 months after the second metastasectomy.
Discussion and conclusions
Peritoneal recurrence is a rare form of HCC. According to the report of the 22nd Nationwide Follow-Up Survey of Primary Liver Cancer in Japan (2012–2013) , of 7494 resected HCC cases, only 28 (0.4%) had peritoneal dissemination. Implantation of tumor cells at time of needle biopsy, RFA, surgical resection, and tumor rupture is the main cause of peritoneal dissemination . There is no clear evidence regarding the treatment of peritoneal HCC recurrence. While peritoneal dissemination in other types of cancer is usually widespread and not indicated for surgery, peritoneal dissemination in HCC is sometimes localized, and several reports have shown that surgical resection of peritoneal recurrence can improve the prognosis of patients with HCC [11, 12]. In our case, the tumor cells were speculated to have been implanted by the rupture of the primary tumor. The disease was well controlled by surgical resection of the recurrent lesion, and the patient is alive 33 months after the initial surgery. Oligoperitoneal recurrence in patients with HCC may receive some benefit from surgical resection.
ICG is used not only for evaluation of liver function but also for surgical navigation, such as detection of tumors or blood flow assessment. ICG fluorescence can be used to detect both primary and extrahepatic lesions in HCC. Sato et al.  reported that the positive predictive value of ICG fluorescence by near-infrared observation in 33 extrahepatic metastatic lesions was 100%, whereas the negative predictive value was 86%. In our case, intraoperative ICG fluorescence imaging was useful for the resection of peritoneal dissemination for the following reasons: First, we were able to clearly distinguish the tumor from the surrounding normal tissue. Especially for the first metastasectomy, the tumor was deeply embedded in the fatty tissue and it was difficult to macroscopically recognize the boundary of the tumor. Second, small lesions that could not be identified by preoperative CT could be detected by ICG fluorescence imaging, and complete resection was achieved. In particular, laparoscopic surgery allows observation of the entire abdominal cavity in a minimally invasive manner. Considering that R0 resection is one of the minimum requirements for surgical resection for peritoneal recurrence, a laparoscopic approach in combination with ICG fluorescence can be a promising strategy to determine the surgical indication.
To assess the efficacy of ICG fluorescence for resection of peritoneal dissemination in patients with HCC, we conducted a literature search using the PubMed database and found seven cases of surgical resection for peritoneal dissemination of HCC using ICG fluorescence imaging, including our case [4,5,6, 10, 14] (Table 1). There were two cases of rupture of primary HCC (cases 2 and 7), and TAE was performed in all cases. In case 4, ICG fluorescence imaging at the time of the initial surgery revealed that the patient had peritoneal metastasis in the omentum. Consequently, surgery for primary HCC was cancelled. In five of the seven cases, the authors were able to intraoperatively identify the lesions using ICG fluorescence that could not be detected by preoperative image analysis. Laparoscopic surgery was performed in three cases, and in two of the three cases, new lesions were detected at a site distant from the main lesion. Regarding the prognosis after resection of peritoneal dissemination, recurrence was observed in case 5 and in our case. In case 5, eight lesions were resected, including those identified intraoperatively by ICG fluorescence, with a maximum diameter of 28 mm, and peritoneal re-recurrence was observed only 2 months after the surgery. Our case also showed multiple lesions with peritoneal recurrence; therefore, careful follow-up of the patient is necessary. Given that R0 resection is the key to surgical resection of peritoneal dissemination, careful laparoscopic examination of the abdominal cavity using ICG fluorescence is an important step and may allow the selection of patients who will truly benefit from surgical resection of peritoneal dissemination. Indeed, in case 4, ICG fluorescence imaging helped physicians decide on the treatment strategy. Systemic treatment, rather than surgical resection, was selected. In our case, surgery was performed 3 days after ICG administration. For hepatic tumors, it is recommended to administer ICG at least 2 days before surgery for clear contrast between tumors and background liver tissue ; however, for extrahepatic metastases, there is no need to consider contrast with the liver tissue, so 1–5 days between ICG administration and surgery may be sufficient .
In conclusion, we report the case of a patient with HCC who underwent surgical resection for peritoneal dissemination. ICG fluorescence imaging may be useful for determining the indications for surgical resection of peritoneal dissemination.
Availability of data and materials
Transcatheter arterial embolization
Protein induced by vitamin K absence or antagonist II
Hung MC, Wu HS, Lee YT, et al. Intraperitoneal metastasis of hepatocellular carcinoma after spontaneous rupture: a case report. World J Gastroenterol. 2008;14:3927–31.
Lee SK, Song MJ. Drop metastasis from hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. Korean J Intern Med. 2017;32:943–4.
Portolani N, Baiocchi G, Gheza F, et al. Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery? World J Surg Oncol. 2014;12:298.
Miyazaki Y, Kurata M, Oshiro Y, et al. Indocyanine green fluorescence-navigated laparoscopic metastasectomy for peritoneal metastasis of hepatocellular carcinoma: a case report. Surg Case Rep. 2018;4:130.
Nakamura M, Hayami S, Ueno M, et al. Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma: a case report. Surg Case Rep. 2018;4:76.
Hayashi H, Shimizu A, Motoyama H, et al. Usefulness and limitation of indocyanine green fluorescence for detection of peritoneal recurrence after hepatectomy for hepatocellular carcinoma: a case report. BMC Surg. 2021;21:107.
Ishizawa T, Fukushima N, Shibahara T, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115:2491–504.
Kudo M, Kitano M, Sakurai T, et al. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study group of Japan. Dig Dis. 2015;33:765–70.
Kudo M, Izumi N, Kokudo N, et al. Report of the 22nd nationwide follow up Survey of Primary Liver Cancer in Japan (2012–2013). Hepatol Res. 2022;52:5–66.
Sasaki S, Takahashi M, Hayashi T, et al. Utility of X-ray and indocyanine green fluorescence imaging in detecting hepatocellular carcinoma dissemination on laparoscopic surgery: a case report. Mol Clin Oncol. 2021;15:259.
Hai S, Okada T, Iimuro Y, et al. Successful laparoscopic extirpation of peritoneal dissemination after hepatectomy for ruptured hepatocellular carcinoma. Asian J Endosc Surg. 2015;8:465–7.
Kurachi K, Suzuki S, Yokoi Y, et al. A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma. J Gastroenterol. 2002;37:571–4.
Satou S, Ishizawa T, Masuda K, et al. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma. J Gastroenterol. 2013;48:1136–43.
He P, Huang T, Fang C, et al. Identification of extrahepatic metastasis of hepatocellular carcinoma using indocyanine green fluorescence imaging. Photodiagnosis Photodyn Ther. 2019;25:417–20.
Franz M, Arend J, Wolff S, et al. Tumor visualization and fluorescence angiography with indocyanine green (ICG) in laparoscopic and robotic hepatobiliary surgery valuation of early adopters from Germany. Innov Surg Sci. 2021;6(2):59–66.
Nanashima A, Tominaga T, Sumida Y, et al. Indocyanine green identification for tumor infiltration or metastasis originating from hepatocellular carcinoma. Int J Surg Case Rep. 2018;46:56–61.
Morita Y, Sakaguchi T, Unno N, et al. Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation. Int J Clin Oncol. 2013;18:232–41.
Kawakita N, Takizawa H, Kondo K, et al. Indocyanine green fluorescence navigation thoracoscopic metastasectomy for pulmonary metastasis of hepatocellular carcinoma. Ann Thorac Cardiovasc Surg. 2016;22:367–9.
Hashimoto M, Sasaki K, Moriyama J, et al. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery. 2013;153(5):727–31.
Iida H, Tani M, Aihara T, et al. New metastasectomy criteria for peritoneal metastasis of hepatocellular carcinoma: a study of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2020;27(10):673–81.
The authors thank Editage (www.editage.com) for English language editing.
There is no financial support to declare associated with this study.
Ethics approval and consent to participate
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tani, Y., Sato, H., Yoshida, R. et al. Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature . J Med Case Reports 16, 222 (2022). https://doi.org/10.1186/s13256-022-03440-5